Recent Updates
Recently added Catalysts
BNTX

BioNTech SE, Mainz, Germany Annual General Meeting in Munich, Germany, 26 June 2020 Voting results - Overview - Only the German version is binding Agenda Item 2 Approval of the actions of the Management Board - accepted

Key Takeaway: BioNTech SE, Mainz, Germany Annual General Meeting in Munich, Germany, 26 June 2020 Voting results - Overview - Only the German version is binding Agenda Item 2 Approval of the actions of the Management Board - accepted 152,033,174 Number of shares for which valid votes were

Full Press Release Details

BioNTech SE, Mainz, Germany
Annual General Meeting in Munich, Germany, 26 June 2020
Voting results - Overview - Only the German version is binding
Agenda Item 2 Approval of the actions of the Management Board - accepted
152,033,174 Number of shares for which valid votes were cast (= 63.826 % of the registered share capital)
152,015,170 Yes votes 99.988 % of the valid votes cast
18,004 No votes 0.012 % of the valid votes cast
Agenda Item 3 Approval of the actions of the Supervisory Board - accepted
73,516,708 Number of shares for which valid votes were cast (= 30.864 % of the registered share capital)
73,497,269 Yes votes 99.974 % of the valid votes cast
19,439 No votes 0.026 % of the valid votes cast
Agenda Item 4 Appointment of the auditor for the 2020 financial year - accepted
195,931,883 Number of shares for which valid votes were cast (= 82.256 % of the registered share capital)
195,927,278 Yes votes 99.998 % of the valid votes cast
4,605 No votes 0.002 % of the valid votes cast
Agenda Item 5 Amendment of the authorization to issue stock options - accepted
195,518,062 Number of shares for which valid votes were cast (= 82.082 % of the registered share capital)
195,449,670 Yes votes 99.965 % of the valid votes cast
68,392 No votes 0.035 % of the valid votes cast
Agenda Item 6 Expansion of options to exclude subscription rights for authorised capital - accepted
195,507,877 Number of shares for which valid votes were cast (= 82.078 % of the registered share capital)
195,492,290 Yes votes 99.992 % of the valid votes cast
15,587 No votes 0.008 % of the valid votes cast
Agenda Item 7 Amendments to the Articles of Association in connection with the invitation to and conduct of general meetings - accepted
195,487,103 Number of shares for which valid votes were cast (= 82.069 % of the registered share capital)
193,271,471 Yes votes 98.867 % of the valid votes cast
2,215,632 No votes 1.133 % of the valid votes cast
Agenda Item 8a Approval of the conclusion of the domination agreement between the Company as controlling company and BioNTech Small Molecules GmbH as dependent company - accepted
195,511,012 Number of shares for which valid votes were cast (= 82.079 % of the registered share capital)
195,505,708 Yes votes 99.997 % of the valid votes cast
5,304 No votes 0.003 % of the valid votes cast
Agenda Item 8b Approval of the conclusion of the domination agreement between the Company as controlling company and BioNTech IVAC GmbH as de-pendent company - accepted
195,510,926 Number of shares for which valid votes were cast (= 82.079 % of the registered share capital)
195,505,442 Yes votes 99.997 % of the valid votes cast
5,484 No votes 0.003 % of the valid votes cast
BioNTech SE, Mainz, Germany
Annual General Meeting in Munich, Germany, 26 June 2020
Voting results - Overview - Only the German version is binding
Agenda Item 8c Approval of the conclusion of the domination agreement between the Company as controlling company and BioNTech Real Estate Holding GmbH as dependent company - accepted
195,510,844 Number of shares for which valid votes were cast (= 82.079 % of the registered share capital)
195,504,260 Yes votes 99.997 % of the valid votes cast
6,584 No votes 0.003 % of the valid votes cast
Agenda Item 8d Approval of the conclusion of the domination and profit and loss transfer agreement between the Company as controlling company and JPT Peptide Technologies GmbH as dependent company - accepted
195,511,026 Number of shares for which valid votes were cast (= 82.079 % of the registered share capital)
195,503,722 Yes votes 99.996 % of the valid votes cast
7,304 No votes 0.004 % of the valid votes cast
Agenda Item 8e Approval of the conclusion of the domination and profit and loss transfer agreement between the Company as controlling company and BioNTech Cell & Gene Therapies GmbH as dependent company - accepted
195,511,435 Number of shares for which valid votes were cast (= 82.079 % of the registered share capital)
195,504,552 Yes votes 99.996 % of the valid votes cast
6,883 No votes 0.004 % of the valid votes cast
Last updated: Jun 26, 2020